Craft

Sartorius

Stock Price

€194.4

2024-10-29

Market Capitalization

€15.3 B

2024-10-29

Revenue

€3.5 B

FY, 2025

Sartorius Summary

Company Summary

Overview
Sartorius is a life sciences company that specializes in biopharmaceutical research and drug development. It operates through two divisions: Bioprocess Solutions and Lab Products and Services. The Bioprocess Solutions division offers the development and production of cell lines, cell culture media and reagents, bioreactors, a variety of technologies for separation, purification and concentration of biological products, and other services. The Lab Products and Services division addresses pharmaceutical, biotech research laboratories, and academic research institutes.
Type
Public
Status
Active
Founded
1870
HQ
Göttingen, DE | view all locations
Website
https://www.sartorius.com/en
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Joachim Kreuzburg

    Joachim Kreuzburg, Chairman of the Executive Board and CEO

    • René Fáber

      René Fáber, Member of the Executive Board

    • Alexandra Gatzemeyer

      Alexandra Gatzemeyer, Member of the Executive Board

    • Petra Müller

      Petra Müller, Head of Investor Relations

      Operating MetricsView all

      Order Intake

      €2.2B
      124.0%

      Q3, 2023

      Production and Sales Sites

      60

      Q3, 2023

      Order Intake (Bioprocess Solutions)

      €1.7B
      132.0%

      Q3, 2023

      LocationsView all

      72 locations detected

      • Göttingen, NDS HQ

        Germany

        Otto-Brenner-Straße 20

      • Bohemia, NY

        United States

        565 Johnson Ave

      • Martínez, Provincia de Buenos Aires

        Argentina

        Cuyo 2889

      • Dandenong South, Victoria

        Australia

        Unit 5, 7-11 Rodeo Drive

      • Wien, Wien

        Austria

        Modecenterstraße 22/Top. Nr. D20 - D24

      • Bruxelles, Bruxelles

        Belgium

        Rue Colonel Bourg 105

      and 66 others

      Sartorius Financials

      Summary Financials

      Revenue (Q1, 2026)
      €899.1M
      Gross profit (Q1, 2026)
      €547.0M
      Net income (Q1, 2026)
      €81.0M
      Cash (Q1, 2026)
      €573.8M
      EBIT (Q1, 2026)
      €153.9M
      Enterprise value
      $19.1B

      Footer menu